Final Program

156 MONDAY • MAY 16
P152
Facilitator:
P153
P154
P155
P156
P157
P158
P159
Facilitator:
P160
P161
P162
P163
Ghrelin Treatment Decreases Lung Inflammation and
Fibrogenesis by Inducing M2 Macrophage Polarization/N.N.
Rocha, M.D.O. Vasconcellos, C.B. Lisboa, G. Guimaraes, G.D.A.
Padilha, L.A. Maia, J.D. Silva, C.M. Takiya, V. Capelozzi, P.L.
Silva, P.R.M. Rocco, Rio de Janeiro, Brazil, p.A3152
A.M. Manicone, MD, Seattle, WA
BRD9 Is a Novel Epigenetic Regulator for Human Alveolar
Macrophages Polarization/Y. Morias, A. Schinwald, T. Naessens,
H. Boyd, D. Cunoosamy, Molndal, Sweden, p.A3153
Induction of IL-17Rb and IL-25 in Human Monocytes and
Macrophages Through the Action of Th2 Cytokine IL-4/N.
Weathington, S.M. Kanth, J.S. Bednash, Q. Gong, R. Mallampalli,
Pittsburgh, PA, p.A3154
The Effect of Tiotropium Bromide in Development of M2
Macrophages in Murine Model of Asthma/M. Jinno, S. Ohta, A.
Tanaka, A. Fujiwara, Y. Uchida, R. Manabe, H. Furukawa, N.
Kuwahara, Y. Fukuda, T. Kimura, K. Hirai, Y. Miyata, T. Homma, M.
Yamamoto, Y. Watanabe, T. Yokoe, H. Sagara, Tokyo, Japan,
p.A3155
Decellularized Wild Type and a-Galactosyltransferase
Knockout Pig Lungs Stimulate M2 Phenotype in Human
Monocyte/Macrophages/S. Wrenn, A. Coffey, F.E. Uhl, J. Bianchi,
B. Dacken, T. Petersen, D.E. Wagner, J.E. Boyson, D.J. Weiss,
Burlington, VT, p.A3156
Distinct Profiles of M2 Macrophage Markers Among Idiopathic
Interstitial Pneumonias/M. Yamashita, R. Saito, M. Ogasawara,
Y. Fukuda, H. Sasano, T. Sugai, K. Yamauchi, Morioka, Japan,
p.A3157
SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of
Macrophage Priming and Activation/Z.C. Chroneos, L. Yang, M.
Carrillo, Y. Wu, S. Diangelo, P. Silveyra, T.M. Umstead, E.S.
Halstead, M. Davies, S. Hu, J. Floros, F.X. McCormack, N.D.
Christensen, Hershey, PA, p.A3158
Critical Role of the Class A Scavenger Receptor on Alveolar
Macrophages in Chronic Obstructive Pulmonary Disease
Airway Inflammation/R. Dong, L. Xie, M. Zhou, Shanghai, China,
p.A3159
S. Sengupta, MD, MPH, Philadelphia, PA
Ethanol-Induced Oxidative Stress and Altered AMPK Signaling
in Human Alveolar Macrophages/L. Kaphalia, B.S. Kaphalia, W.J.
Calhoun, Galveston, TX, p.A3160
S-nitrosoglutathione Reductase (GSNOR) Deficiency Impairs
Macrophage Phenotypic Differentiation/C. Guo, J. Gow, M.
Govendraj, A.J. Gow, Piscataway, NJ, p.A3161
Ursolic Acid Inhibits Cigarette Smoke-Induced Alveolar
Macrophages Activity Injury Via ERK Signaling Pathway/Y. Yin,
G. Hou, Q. Wang, E. Li, J. Kang, Shen Yang City, China, p.A3162
Increased Number of Macrophages in the Induced Sputum for
Patients with Acute Myocardial Infarction/N. Kononova, G.
Einvik, A. Hoiseth, A. Neukamm, T. Omland, V. Søyseth, Oslo,
Norway, p.A3163
P164
P165
B33
Alveolar Macrophage-Mediated Efferocytosis in Alpha-1
Antitrypsin Deficiency/U. Parthasarathy, K. Krotova, M. Brantly,
Gainesville, FL, p.A3164
miR-451 Regulates Allergic Lung Inflammation Via
Sirt2-Mediated Alternative Macrophage Activation/Y.G. Lee, S.
Chung, M. Karpurapu, M.N. Ballinger, B.F. Reader, J. Deng, Q.
Feng, J. Christman, Columbus, OH, p.A3165
THEMATIC POSTER SESSION
ANTIOXIDANTS, VITAMINS AND RELATED
PATHWAYS IN AIRWAYS DISEASE
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area B, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P169
P170
P171
P172
P173
P174
J.S. Deshane, PhD, Birmingham, AL
Vitamin E Isoform g-Tocotrienol Attenuates Cigarette
Smoke-Induced Chronic Obstructive Pulmonary Disease/
H.Y. Peh, W.D. Tan, T.K. Chan, C.N. Ong, W.F. Wong, Singapore,
Singapore, p.A3166
Impact of Vitamin D3 Deficiency on Airway Vitamin D
Metabolism and Inflammation in a Murine Model of Atopic
Chronic Rhinosinusitis/J.K. Mulligan, R. Schlosser, W. Pasquini,
B.P. O’Connell, C. Atkinson, Charleston, SC, p.A3167
Cord Blood Vitamin D Levels and Gene Expression Profiles at
Birth Are Associated with Wheezing in the First Year of Life:
Results from the Vitamin D Antenatal Asthma Reduction Trial
(VDAART)/A. Al Garawi, V.J. Carey, W. Qiu, H. Mirzakhani, A.A.
Litonjua, S.T. Weiss, Boston, MA, p.A3168
Vitamin D Supplementation in Pregnant Women of Different
Races and the Risk of Asthma/Recurrent Wheeze in the Child:
Findings from the Vitamin D Antenatal Asthma Reduction Trial
(VDAART)/H.M. Wolsk, B.J. Harshfield, N. Laranjo, V.J. Carey, G.T.
O’Connor, M. Sandel, R.C. Strunk, L.B. Bacharier, R.S. Zeiger, M.
Schatz, B.W. Hollis, S.T. Weiss, A.A. Litonjua, Boston, MA, p.A3169
Effect of Vitamin D on Cytokines Gene Expression and
Corticosteroid Receptors of Asthmatic Patients in the United
Arab Emirates/B. Mahboub, A. Alzaabi, R.M. Seliem, L.I. Salameh,
S.M. Toor, F.S. Shendi, O.M. Al Ali, B.K. Saffarini, W.T. Erabia, A.
Mogas, S. Audusseau, V. Narayanan, Q. Hamid, Sharjah, United
Arab Emirates, p.A3170
Age and Gender-Specific Protective Effects of Superoxide
Dismutase in Asthma Severity/S.A.A. Comhair, S.M.
Baicker-McKee, E. Bleeker, M. Castro, J.V. Fahy, E. Israel, N.
Jarour, B.D. Levy, D. Mauger, S.E. Wenzel, W.G. Teague, B.
Gaston, S.C. Erzurum, Cleveland, OH, p.A3171
ATS 2016 • San Francisco